Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies…
Carbonxt Group (CG1:AU) has announced Convertible Note and Placement Download the PDF here. This post appeared first on investingnews.com
